| Literature DB >> 22254136 |
Stella D Bouziana1, Konstantinos Tziomalos.
Abstract
Stroke is a devastating event that carries a potential for long-term disability. Malnutrition is frequently observed in patients with stroke, and dysphagia contributes to malnutrition risk. During both the acute phase of stroke and rehabilitation, specific nutritional interventions in the context of a multidisciplinary team effort can enhance the recovery of neurocognitive function. Early identification and management of malnutrition with dietary modifications or specific therapeutic strategies to ensure adequate nutritional intake should receive more attention, since poor nutritional status appears to exacerbate brain damage and to contribute to adverse outcome. The main purpose of nutritional intervention should be the prevention or treatment of complications resulting from energy-protein deficit. This paper reviews the evaluation and management of malnutrition and the use of specialized nutrition support in patients with stroke. Emphasis is given to enteral tube and oral feeding and to strategies to wean from tube feeding.Entities:
Year: 2011 PMID: 22254136 PMCID: PMC3255318 DOI: 10.1155/2011/167898
Source DB: PubMed Journal: J Nutr Metab ISSN: 2090-0724
Micronutrients and mechanisms through which their deficiencies induce cerebrovascular alterations and increase the risk of stroke.
| Micronutrient | Mechanism |
|---|---|
|
| |
| Cofactor in homocysteine metabolism | Hyperhomocysteinemia (potentially atherogenic) |
|
| |
|
| |
| (i) B6 and B12: cofactors in homocysteine metabolism | (i) Hyperhomocysteinemia (potentially atherogenic) |
| (ii) Potentially antioxidants | (ii) Oxidative stress |
|
| |
|
| |
| (i) Controls parathormone levels | (i) Secondary hyperparathyroidism: |
| (ii) Suppresses cholesterol uptake by the macrophages and foam cell formation | – Insulin resistance and pancreatic b-cell dysfunction→type 2 diabetes mellitus |
| – Activation of the rennin-angiotensin-aldosterone system→hypertension | |
| (iii) Increases the size of high-density lipoprotein particles | – Stimulation of systemic and vascular inflammation→atherogenesis |
| (ii) Atherogenesis | |
|
| |
|
| |
| Antioxidants | Oxidative stress |
|
| |
|
| |
| (i) Activates brain protein synthesis | (i) Neurocognitive impairment |
| (ii) Controls newly formed synapses | (ii) Impaired neurotransmission |
| (iii) Cofactor of superoxide dismutase | (iii) Oxidative stress |
Indications for enteral nutrition support in stroke patients.
| Indications for enteral nutrition support |
|---|
| Dysphagia |
| Inadequate nutritional intake due to |
| (i) Reduced consciousness level |
| (ii) Depression |
| (iii) Poor oral hygiene |
| (iv) Xerostomia |
| (v) Reduced mobility |
| (vi) Arm or facial weakness |
| (vii) Fatigue |
| (viii) Vision, speech, and language impairment |
| (xi) Cognitive deficits |
| Increased metabolic demands |